Regulatory policy

Legal and regulatory policy content focused on law and governance

Managing Editor, US Regulatory Analysis for the Pink Sheet at Citeline Regulatory. Experienced in regulatory analysis and editorial management. Focused on delivering insightful regulatory content.

Senior editor of the Pink Sheet and Scrip at Citeline, reporting on regulatory and reimbursement policy news for the pharmaceutical industry.

Financial regulation, corporate governance, ESG, fintech, tech, telecom, M&A, antitrust, tax policy

Government policy, politics, companies, social and economic trends

Specializes in policy and regulation with engaging digital content focus

Senior market reporter with extensive experience on Chicago trading floors

Regulatory affairs and health reporting with editorial expertise

EU policy and chemical regulation expertise, managing editorial content

Senior Editor covering US FDA drug and biologic regulation and approvals, providing expert insights in pharmaceutical regulation.

Covering agencies with focus on FOIA, FARA, LDA, QPR and related topics

Focus on policy, financial regulation, press, radio production, and law review editing

Spectrum policy, 5G, WiFi, and airwaves regulatory coverage

Financial and regulatory correspondent with experience managing homepage and editorial teams

Competition policy and EU regulation coverage from Brussels

Policy and regulation content focused on medtech industry insights

Banking regulations and risk management in Asia Pacific region

Biopharma regulatory and policy content for The Pink Sheet publications

Health insurance and related healthcare topics

Environmental law and policy content focused on legal and regulatory issues

Policy reporting with data and analytics expertise

Experienced journalist covering regulatory and legislative issues in Washington, D.C.

Complex policy challenges analysis and research in the US

Experienced writer and policy expert based in Brussels, focusing on policy analysis.

Food and Drug Administration and prescription drug industry insights

Health and FDA coverage, Prescription Pulse co-author

Tax policy and related financial regulatory content

Tax policy and congressional tax reporting analysis and content

Focus on markets and financial content

Competition and corporate conduct issues in health care and pharma